Effects of naloxone-precipitated morphine withdrawal on glutamate-mediated signaling in striatal neurons in vitro.
Chartoff
Elena H
EH
Department of Psychiatry, Harvard Medical School at McLean Hospital, Belmont, Massachusetts 02478, USA.
Papadopoulou
Maria
M
Konradi
Christine
C
Carlezon
William A
WA
D000818:Animals; D001552:Benzazepines / Q000494:pharmacology; D002478:Cells, Cultured; D017362:Cyclic AMP Response Element-Binding Protein / Q000096:biosynthesis / Q000502:physiology; D005971:Glutamates / Q000502:physiology*; D009021:Morphine Dependence / Q000503:physiopathology* / Q000523:psychology; D009270:Naloxone / Q000494:pharmacology*; D009292:Narcotic Antagonists / Q000494:pharmacology*; D017072:Neostriatum / Q000166:cytology / Q000502:physiology*; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D051381:Rats; D015398:Signal Transduction / Q000187:drug effects*; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology* / Q000523:psychology
D001552:Benzazepines; D017362:Cyclic AMP Response Element-Binding Protein; D005971:Glutamates; D009292:Narcotic Antagonists; D009270:Naloxone; C071262:SK&F 82958